USA Financial Formulas’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.76K Sell
22
-136
-86% -$34.9K ﹤0.01% 316
2026
Q2
$39.8K Buy
158
+155
+5,167% +$33.3K 0.01% 307
2026
Q1
$652 Hold
3
– – ﹤0.01% 365
2025
Q4
$685 Buy
+3
New +$683 ﹤0.01% 339
2022
Q3
$3K Sell
20
-5,219
-100% -$749K ﹤0.01% 139
2022
Q2
$802K Sell
5,239
-1,250
-19% -$191K 1% 40
2022
Q1
$1.05M Buy
6,489
+6,463
+24,858% +$939K 1.13% 23
2021
Q4
$4K Sell
26
-560
-96% -$66.2K ﹤0.01% 224
2021
Q3
$63K Buy
586
+102
+21% +$11.7K 0.06% 178
2021
Q2
$55K Buy
484
+459
+1,836% +$51.7K 0.05% 208
2021
Q1
$3K Sell
25
-754
-97% -$80.6K ﹤0.01% 244
2020
Q4
$83K Buy
+779
New +$74.9K 0.07% 151
2018
Q4
– Sell
-2,585
Closed -$240K – 316
2018
Q3
$240K Sell
2,585
-31,475
-92% -$2.98M 0.06% 243
2018
Q2
$3.22M Sell
34,060
-258
-0.8% -$25.2K 0.78% 55
2018
Q1
$3.25M Sell
34,318
-4,945
-13% -$543K 0.78% 55
2017
Q4
$3.8M Buy
+39,263
New +$3.7M 0.9% 44
2017
Q3
– Sell
-5,887
Closed -$427K – 241
2017
Q2
$427K Buy
5,887
+1,368
+30% +$92K 0.1% 186
2017
Q1
$294K Buy
4,519
+363
+9% +$22.8K 0.07% 198
2016
Q4
$260K Buy
+4,156
New +$254K 0.06% 210
2016
Q3
– Sell
-3,233
Closed -$200K – 219
2016
Q2
$200K Buy
+3,233
New +$197K 0.05% 203

Other funds holding ABBV

USA Financial Formulas's ABBV Position: Q3 2026 in Review

USA Financial Formulas reduced its AbbVie (ABBV) stake by 86% in Q3 2026, selling an estimated $34.9K and leaving 22 shares worth $5.76K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

USA Financial Formulas first reported a position in ABBV in Q2 2016 and has held it in 20 quarters since. The position peaked at $3.8M in Q4 2017. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • USA Financial Formulas held 22 shares of AbbVie worth $5.76K as of Q3 2026.
  • USA Financial Formulas sold 136 AbbVie shares in Q3 2026, an estimated $34.9K.
  • AbbVie made up ﹤0.01% of USA Financial Formulas's portfolio in Q3 2026, its #316 holding.
  • USA Financial Formulas first reported a position in AbbVie in Q2 2016 and has held it in 20 quarters since.
  • USA Financial Formulas's AbbVie position peaked at $3.8M in Q4 2017.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.